B

BMP Pharma Trading AG
XBER:BMP

Watchlist Manager
BMP Pharma Trading AG
XBER:BMP
Watchlist
Price: 5.3 EUR Market Closed
Market Cap: €27.8m

Net Margin

85 055.6%
Current
No historical data
Comparison unavailable

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
85 055.6%
=
Net Income
€3.8m
/
Revenue
€4.5k

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
85 055.6%
=
Net Income
€3.8m
/
Revenue
€4.5k

Peer Comparison

Country Company Market Cap Net
Margin
DE
BMP Pharma Trading AG
XBER:BMP
27.8m EUR
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Eli Lilly and Co
NYSE:LLY
972.2B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.5B USD
Loading...
US
Abbvie Inc
NYSE:ABBV
393.1B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.1B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
272.1B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...

Market Distribution

Higher than 100% of companies in Germany
Percentile
100th
Based on 3 835 companies
100th percentile
85 055.6%
Low
-222 027.4% — -2%
Typical Range
-2% — 6%
High
6% — 85 055.6%
Distribution Statistics
Germany
Min -222 027.4%
30th Percentile -2%
Median 2.2%
70th Percentile 6%
Max 85 055.6%

BMP Pharma Trading AG
Glance View

Market Cap
27.8m EUR
Industry
N/A

B.M.P.Pharma Trading AG engages in the selling and distribution of pharmaceutical raw materials, dietary supplement products and raw materials of the veterinary industry. The company is headquartered in Norderstedt, Schleswig-Holstein. The company went IPO on 2004-04-21. Its offers four types of pharmaceutical preparations: herbal and fruit extracts; narcotics, including pemoline, morphine monohydrate and others; food additives, such as L-carnitine, vinpocetine and others, and veterinary products. As of December 31, 2011, the Company's scope of consolidated encompassed B.M.P. Bulk Medicines & Pharmaceuticals GmbH, in which it held a 100%-stake, ALPHA Trading GmbH (100%-stake), B.M.P. Pharma Trading Corporation (100%-stake), and B.M.P. Biotec GmbH, in which the Company held a 51%-stake. Apart from B.M.P. Pharma Trading Corporation, which was based in Nashville in the United States, all subsidiaries were based in Germany.

BMP Intrinsic Value
Not Available
B
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
85 055.6%
=
Net Income
€3.8m
/
Revenue
€4.5k
How has Net Margin changed over time?

Over the last 3 years, BMP Pharma Trading AG’s Net Margin has increased from 5 266% to 85 055.6%. During this period, it reached a low of -1 892.3% on Jun 30, 2021 and a high of 85 055.6% on Jul 30, 2022.

Back to Top